Although cell-based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual-track regulatory framework for cell-based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell-based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell-based therapy.

Original languageEnglish
Pages (from-to)1045-1047
Number of pages3
JournalClinical and Translational Science
Issue number6
Publication statusPublished - Nov 2020

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan'. Together they form a unique fingerprint.

Cite this